Pitogo, Regin S.

HRN: 21-66-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2022
07/13/2022
IV
500 Mg
TID
Infectious Diarrhea
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: